Name
INROMED OÜ
Registry code
10472088
VAT number
EE101170716
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
28.08.1998 (26)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86221 - Provision of specialised medical treatment
395 402 €
118 138 €
30%
2 451 €
(estimate is approximate)
120 953 €
5
Submitted
No tax arrears
98%
78%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Indrek Roose 12.03.1966 (58) | 50% - 1 278.00 EUR | Board member | Direct ownership | |
| Jaak Kivisaar 11.06.1960 (64) | 50% - 1 278.00 EUR | Board member | Direct ownership | |
| Helve Hanson 01.09.1955 (69) | - | - | - | Founder |
| Mati Vettik 02.06.1952 (72) | - | - | - | Founder |
| 2019 17.06.2020 | 2020 28.06.2021 | 2021 15.06.2022 | 2022 17.05.2023 | 2023 25.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 127 730 € | 165 467 € | 282 674 € | 337 685 € | 395 402 € |
| Net profit (loss) for the period | 16 641 € | 36 823 € | 82 972 € | 83 444 € | 118 138 € |
| Profit Margin | 13% | 22% | 29% | 25% | 30% |
| Current Assets | 63 671 € | 86 355 € | 150 241 € | 104 232 € | 149 702 € |
| Fixed Assets | 43 565 € | 33 017 € | 22 469 € | 12 000 € | 2 400 € |
| Total Assets | 107 236 € | 119 372 € | 172 710 € | 116 232 € | 152 102 € |
| Current Liabilities | 26 447 € | 20 211 € | 21 909 € | 23 395 € | 31 149 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 80 789 € | 99 161 € | 150 801 € | 92 837 € | 120 953 € |
| Employees | 3 | 3 | 3 | 4 | 5 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 30 156.08 € | 25 840.33 € | 8 |
| 2023 Q4 | - | 20 437.62 € | 21 646.97 € | 8 |
| 2023 Q3 | - | 19 099.68 € | 16 038.28 € | 6 |
| 2023 Q2 | - | 29 969.49 € | 21 405.9 € | 6 |
| 2023 Q1 | - | 24 225.88 € | 21 853.01 € | 6 |
| 2022 Q4 | - | 16 626.59 € | 17 510.33 € | 6 |
| 2022 Q3 | - | 48 028.73 € | 15 131.51 € | 6 |
| 2022 Q2 | - | 15 133.14 € | 15 921.43 € | 5 |
| 2022 Q1 | - | 16 791.84 € | 17 670.64 € | 5 |
| 2021 Q4 | - | 12 728.27 € | 13 372.11 € | 5 |
| 2021 Q3 | 250 € | 18 102.15 € | 12 441.48 € | 5 |
| 2021 Q2 | - | 13 244.19 € | 13 917.76 € | 5 |
| 2021 Q1 | - | 13 295.45 € | 11 744.16 € | 5 |
| 2020 Q4 | - | 9 868.6 € | 10 375.15 € | 5 |
| 2020 Q3 | - | 9 290.61 € | 8 364.94 € | 5 |
| 2020 Q2 | - | 4 991.38 € | 5 302.34 € | 5 |
| 2020 Q1 | - | 8 772.21 € | 8 280.77 € | 5 |
